ROIV
Roivant Sciences Ltd. · Healthcare
Director Meghan Fitzgerald sold $203K of Roivant Sciences Ltd.
Sold$203,152
$39.74Price
5,112Shares
−12%Stake
What ROIV did after the filing
- The stock from Fri, Sep 18 open, $40.11
- −12.9%
- S&P 500, same days
- +1.0%
22 of 30 trading days so far, to the Oct 20 close.
Traded Tue, Sep 15. Filed Thu, Sep 17, 6:42 PM ET, after the close. Returns use the Sep 18 open and the Oct 20 close. Not investment advice.